Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-07-11-Speech-3-377"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20070711.32.3-377"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
".
Madam President, ladies and gentlemen, the export mechanism provided for in the decision of 30 August 2003 has added such a number of restrictions and administrative/technical obstacles that to date, as is pointed out by ‘Médecins sans frontières’ in a publication from September 2006, it has never been used. Parliament asked the Commission and the Council to make a specific commitment in its resolution of 2 December 2004.
On 30 November 2006 the European Parliament again adopted a determined position on the issue of access to medicines in the south of the world and unanimously adopted a resolution calling on the Commission, and I quote, ‘to recognise, five years after the adoption of the Doha Declaration, that its application has been a failure, inasmuch as the WTO has received no notification from an exporting or importing country of compulsory medicines nor any such notification under the Decision of 30 August 2003 of the General Council of the WTO on implementing paragraph 6 of the Doha Declaration’. Secondly, Parliament called on them ‘to take the necessary steps within the WTO, in association with the developing countries, to modify the TRIPS Agreement and its provisions based on the Decision of 30 August 2003 …, in order in particular to abolish the complex and time-consuming procedural steps in the authorisation of compulsory licences’.
So far, six months later, neither the Council nor the Commission, despite having been requested to do so by all the parliamentary groups, has not dignified the European Parliament with any reply. Defending to the bitter end a mechanism such as that of 30 August 2003, reproduced word for word in the amendment to the TRIPS agreements that the EU would like to ratify, signifies a very clear choice of sides: it means siding with the large pharmaceutical multinationals and abandoning millions of patients in poor countries to the mercy of diseases that, in their case, are fatal, such as AIDS, tuberculosis, malaria and dozens of other forgotten illnesses, without research or treatment. This is a choice that this Chamber, convinced as it is of the primacy of human rights for all over the profit of a few, cannot accept."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples